Literature DB >> 20839969

Improving the reporting of interventions in clinical trials of acupuncture: the updated and revised STRICTA.

Hugh MacPherson, Kim A Jobst.   

Abstract

Mesh：

Year:  2010        PMID： 20839969     DOI： 10.1089/acm.2010.0558

Source DB:  PubMed          Journal:  J Altern Complement Med        ISSN： 1075-5535            Impact factor:   2.579


× No keyword cloud information.
  5 in total

1.  Reporting quality of sham needles used as controls in acupuncture trials: a methodological evaluation.

Authors:  Ye-Seul Lee; Song-Yi Kim; Mariah Kim; Minseo Kim; Jiyoon Won; Hyangsook Lee; Myeong Soo Lee; Younbyoung Chae
Journal:  Chin Med       Date:  2022-05-31       Impact factor: 4.546

2.  The optimized acupuncture treatment for neck pain caused by cervical spondylosis: a study protocol of a multicentre randomized controlled trial.

Authors:  Zhao-Hui Liang; Zhong Di; Shuo Jiang; Shu-Jun Xu; Xiao-Ping Zhu; Wen-Bin Fu; Ai-Ping Lu
Journal:  Trials       Date:  2012-07-09       Impact factor: 2.279

3.  Effectiveness of acupuncture intervention for neck pain caused by cervical spondylosis: study protocol for a randomized controlled trial.

Authors:  Qinghui Que; Xiaode Ye; Quangui Su; Yan Weng; Jianfeng Chu; Lijuan Mei; Wenwen Huang; Renhui Lu; Guohua Zheng
Journal:  Trials       Date:  2013-06-22       Impact factor: 2.279

Review 4.  A Systematic Review of Reporting Tools Applicable to Sexual and Reproductive Health Programmes: Step 1 in Developing Programme Reporting Standards.

Authors:  Anna Kågesten; Ӧzge Tunçalp; Moazzam Ali; Venkatraman Chandra-Mouli; Nhan Tran; A Metin Gülmezoglu
Journal:  PLoS One       Date:  2015-09-29       Impact factor: 3.240

5.  Pregnancy outcome treated with stage-by-stage acupuncture and moxibustion therapy based on the chong channel being sea of blood theory in repeated IVF-ET failure patients: A randomized controlled trial.

Authors:  Liwei Xing; Jinlong Xu; Qiong Zhang; Li Li; Yunxiu Li; Haina Zhuang; Zhuojun Yuan; Rong Zhao; Yanping Ma
Journal:  Medicine (Baltimore)       Date:  2020-11-20       Impact factor: 1.817
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.